A pilot study to increase cascade genetic testing in families with hereditary cancer syndromes.
Steven J. Katz(University of Michigan), Allison W. Kurian(Stanford University), Rachel Tocco(University of Michigan), Rachel Hodan(Cancer Institute (WIA)), Lawrence C. An(University of Michigan), Sarah T. Hawley(VA Ann Arbor Healthcare System), Kevin C. Ward(Emory University)
Cited by 0
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660
Genetic/Familial High-Risk Assessment: Breast and Ovarian
|Journal of the National Comprehensive Cancer Network|2010|650